Lipella Pharmaceuticals I...
(LIPO)
undefined
undefined%
At close: undefined
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -2.65 | -13.85 | -4.41 | -123.16 | -132.32 |
| PS Ratio | 27.24 | 195.25 | 31.84 | 8.51 | 11.78 |
| PB Ratio | 3.89 | 7.69 | 5.80 | 17.66 | -69.16 |
| P/FCF Ratio | -3.87 | -19.64 | -8.35 | -286.38 | -209.22 |
| P/OCF Ratio | -3.89 | -19.64 | -8.35 | -286.38 | -209.22 |
| OCF/S Ratio | -1.75 | -2.49 | -0.95 | -0.01 | -0.01 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.07 | -0.21 |
| Quick Ratio | 2.22 | 1.25 | 1.33 | 0.84 | 0.18 |
| Current Ratio | 2.22 | 1.23 | 1.33 | 0.84 | 0.18 |
| Asset Turnover | 0.13 | 0.03 | 0.13 | 1.01 | 5.84 |
| Interest Coverage | -109.37 | -67.36 | -70.08 | -1.78 | -1.60 |
| Return on Equity (ROE) | -146.89% | -55.52% | -131.52% | -14.34% | 52.26% |
| Return on Assets (ROA) | -129.12% | -43.63% | -93.01% | -6.96% | -52.01% |
| Return on Capital (ROIC) | -148.69% | -54.27% | -114.56% | -7.61% | 115.05% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | -143.97% | -320.86% | -115.43% | -0.37% | 0.43% |
| Net Profit Margin | -256.83% | -352.43% | -180.47% | -1.73% | -2.23% |